Vedere Bio II
Biotechnology ResearchView the employees at
Vedere Bio II-
Ergun Akturk Scientist, Analytical Development, CMC - Viral Vector
-
Cambridge, Massachusetts, United States
-
Top 10%
John Emmett Biotechnology graduate with research background and entrepreneurial mindset-
Boston, Massachusetts, United States
-
Rising Star
Katie Light Sr. Research Associate at Vedere Bio II-
Top 10%
Marcio Ribeiro PhD in Cellular and Molecular Biology | Neuroscience and Ophthalmology | AAV-mediated gene therapy | Drug Discovery-
Cambridge, Massachusetts, United States
-
Rising Star
Overview
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.
-